The US Department of Homeland Security this week published an updated advisory covering vulnerabilities associated with Abbott (NYSE:ABT) subsidiary St. Jude Medical’s Merlin@home devices. The agency warned that a vulnerability within the Merlin@home system could allow a third party to remotely “access or influence communications” between Merlin.net and transmitter endpoints, which could drain the battery or send […]
Search Results for: st jude
St Jude releases FDA-cleared Merlin@home cybersecurity update
Updated with comment from Muddy Waters. Abbott (NYSE:ABT) subsidiary St. Jude Medical said today it launched a cybersecurity update for its Merlin@home remote monitoring system designed for use with implantable pacemakers and defibrillator devices. The Little Canada, Minn.-based company said the move was made to “complement the company’s existing measures and further reduce the extremely low […]
St. Jude Medical Acquires St Jude Medical Systems AB (2008)
St. Jude Medical Acquires St Jude Medical Japan Co. Ltd. (2002)
Federal Circuit deals Abbott’s St. Jude Medical a setback in catheter IP case
A Federal Circuit court ruled that Abbott (NYSE:ABT) must face patent infringement claims going back to St. Jude Medical. Abbott acquired St. Jude Medical for $25 billion in 2017. A year ago, it won a patent dispute over the method for using a double catheter in heart failure patients. Niazi Licensing sued St. Jude in […]
Abbott to pay $66M to settle suits involving St. Jude Medical and Alere
Abbott (NYSE:ABT) has reached settlements with the U.S. Department of Justice over False Claims Act lawsuits involving St. Jude Medical and Alere — two companies it spent billions of dollars to acquire in 2017. The Abbott Park, Ill.-based medtech giant will pay nearly $66 million as part of the settlements. Without admitting liability in either […]
St. Jude Medical founder and his Medical 21 raise $3M
Raising money for a startup company during a pandemic is no cakewalk, according to Manny Villafaña. But he did it. Medical 21, the latest venture for the founder of St. Jude Medical, has raised another $3 million in an equity offering, according to an SEC filing. The most recent round brings the Minneapolis-based start-up’s total funding […]
Abbott’s St. Jude Medical wins patent spat over catheterization method
St. Jude Medical, now part of Abbott, has won a patent dispute over a method for using a double catheter in heart failure patients. Niazi Licensing’s patent, issued in 2003 for the double catheter system, describes it as better suited for “use in the coronary sinus, especially in patients suffering from congestive heart failure,” according […]
St. Jude Medical founder and his Medical 21 raise $1.1m
St. Jude Medical founder Manny Villafaña’s Medical 21 filed an amendment to an SEC Form D to reveal that it raised more than $1.1 million in an equity offering. The Minneapolis-based company raised a total of $1.14 million in a $10 million offering, leaving $8.86 million remaining to be sold, according to the SEC filing. […]
Humana sues Abbott’s St. Jude Medical over CRM batteries
Humana (NYSE:HUM) leveled a lawsuit against Abbott (NYSE:ABT) subsidiary St. Jude Medical seeking to recoup payments it made for cardiac rhythm management devices that were later recalled due to a battery issue. In October 2016 St. Jude publicly revealed the risk that the lithium-based batteries used in its implantable cardioverter defibrillators and cardiac resynchronization therapy […]
Study finds fault with ICD leads that Abbott inherited from St. Jude Medical
A review of FDA adverse event reports has revealed that some Abbott (NYSE:ABT) implantable cardioverter defibrillator (ICD) leads were much more likely than those made by Boston Scientific or Medtronic to fail due to internal insulation breaches (IBR). Researchers at the Minneapolis Heart Institute Foundation combed through the FDA MAUDE database from 2008 to 2018 for reports […]
